(Q31007181)

28 June 2017

Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts (English)

1 reference

xanthine oxidase inhibitor

28 June 2017

0 references

5

Eduardo Marbán

1 reference

28 June 2017

Anna V Naumova

1

1 reference

28 June 2017

Vadappuram P Chacko

2

1 reference

28 June 2017

Ronald Ouwerkerk

3

1 reference

28 June 2017

Linda Stull

4

1 reference

28 June 2017

Robert G Weiss

6

1 reference

28 June 2017

language of work or name

1 reference

23 September 2005

1 reference

American Journal of Physiology Heart and Circulatory Physiology

28 June 2017

1 reference

28 June 2017

290

1 reference

28 June 2017

H837-43

1 reference

28 June 2017

2

1 reference

Myocardial oxygenation at high workstates in hearts with left ventricular hypertrophy

28 June 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Preservation of cardiac function and energy reserve by the angiotensin-converting enzyme inhibitor quinapril during postmyocardial infarction remodeling in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Changes of myocardial high-energy phosphates with the cardiac cycle during acute or chronic myocardial stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Is the failing heart energy starved? On using chemical energy to support cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Regional biochemical remodeling in non-infarcted tissue of rat heart post-myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Cardiac magnetic resonance imaging in small animal models of human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Functional and energetic consequences of chronic myocardial creatine depletion by beta-guanidinopropionate in perfused hearts and in intact rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Three-dimensional31P magnetic resonance spectroscopic imaging of regional high-energy phosphate metabolism in injured rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Tricarboxylic acid cycle activity in postischemic rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00831.2005

10.1152/AJPHEART.00831.2005

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference